Jasper Therapeutics's total assets for Q2 2025 were $46.47M, a decrease of -19.33% from the previous quarter. JSPR total liabilities were $22.96M for the fiscal quarter, a 49.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.